FDA Will Inspect Guidant Facilities; Design Change Guidance On Horizon
This article was originally published in The Gray Sheet
Executive Summary
FDA is planning "a comprehensive, onsite inspection" of Guidant's manufacturing facilities following the firm's recent recalls of several implantable defibrillators and pacemakers, an agency spokesperson said
You may also be interested in...
Guidant Makes Prizm 2 DR Recall Official, Adds More Devices To Warning List
Guidant will offer free replacements of certain ICD and CRT-D models following the failure of a small number of the devices, but the firm is not recommending substitution across the board
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.